Grand Pharmaceutical Group Limited (HKG:0512)

Market Cap	26.47B +74.6%
Revenue (ttm)	11.70B +10.6%
Net Income	2.08B -13.7%
EPS	0.59 -13.8%
Shares Out	3.50B
PE Ratio	12.72
Forward PE	12.50
Dividend	0.26 (3.44%)
Ex-Dividend Date	Apr 14, 2025

Volume	4,032,000
Average Volume	3,993,513
Open	7.54
Previous Close	7.56
Day's Range	7.45 - 7.71
52-Week Range	4.37 - 10.20
Beta	0.86
RSI	35.82
Earnings Date	Mar 20, 2026

About HKG:0512

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additive...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 12,440
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0512

Financial Performance

In 2024, HKG:0512's revenue was 11.64 billion, an increase of 10.59% compared to the previous year's 10.53 billion. Earnings were 2.47 billion, an increase of 31.30%.